ProfileGDS5678 / 1431803_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 7% 7% 7% 6% 7% 7% 7% 7% 7% 7% 7% 6% 7% 7% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.163697
GSM967853U87-EV human glioblastoma xenograft - Control 22.143347
GSM967854U87-EV human glioblastoma xenograft - Control 32.142157
GSM967855U87-EV human glioblastoma xenograft - Control 42.070756
GSM967856U87-EV human glioblastoma xenograft - Control 52.126587
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.183037
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.179927
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.125337
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.120657
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.138217
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.126327
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.112756
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.135047
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.133597